The 2025 National Health Care Fraud Takedown: The Billing Behind the Billions

Whistleblower Justice Network

The 2025 national Medicare fraud takedown was a coordinated healthcare enforcement action announced on June 30, 2025, with criminal charges against 324 defendants involving more than $14.6 billion in alleged intended loss. The cases reached Medicare, Medicaid, Medicare Advantage and private insurers. Behind that enormous headline were more recognizable allegations: equipment never delivered, orders built from stolen identities, treatment chosen for its billing value and companies controlled by someone other than their listed owner. If you know who ordered the product, who received it or who controlled the payment, you may recognize the business behind the number.

What the National Announcement Counted

The 2025 healthcare fraud takedown included 96 doctors, nurse practitioners, pharmacists and other licensed medical professionals. Cases spanned 50 federal districts and 12 State Attorneys General’s Offices. The Justice Department described it as its largest health care fraud takedown by intended loss.

The Health Care Fraud Unit of the Justice Department’s Criminal Division coordinated the action with U.S. Attorneys’ Offices and federal investigative partners. The Department of Health and Human Services Office of Inspector General, the FBI, the Drug Enforcement Administration and other federal and state agencies investigated the cases.

The previous record was the 2020 national action, which charged more than $6 billion in allegedly false claims to federal healthcare programs and private insurers. The latest alleged schemes more than doubled that record.

For an insider comparing the business to a national headline, the useful question is which claim reached which payer. Medicare and Medicaid fraud can appear in the same announcement while involving different payment systems and investigators.

Civil Settlements Beside a Vast Criminal Takedown

Alongside the criminal charges, the government announced civil charges against 20 defendants involving $14.2 million in alleged fraud, and civil settlements with 106 defendants totaling $34.3 million. We see a striking contrast: civil settlements on a much smaller scale than the alleged schemes behind the headline.

The 2025 Medicare operation prevented payments exceeding $4 billion, according to the Centers for Medicare and Medicaid Services. The agency also suspended or revoked the billing privileges of 205 providers in the months before the takedown.

Gold Rush Within the 2025 National Action

Operation Gold Rush accounted for approximately $10.6 billion in alleged false Medicare claims within the national action. The criminal indictment alleged a network that acquired already enrolled durable medical equipment companies, used nominee owners and false ownership submissions, and billed for equipment never delivered. The national announcement described stolen identities belonging to more than one million Americans and claims for urinary catheters and other supplies.

An enrolled supplier gave the alleged scheme an existing way into Medicare billing. The person listed as owner, the person directing the claims and the person controlling the money could occupy different places in the arrangement. The indictment alleged that company accounts received the proceeds and that money moved through shell entities and foreign accounts. Ownership filings and bank authority were part of the scheme’s mechanics, alongside the claims themselves.

For someone handling beneficiary identities and medical orders, that is a concrete discrepancy: the patient and prescriber information on a claim may look complete while the underlying order or delivery never happened. We see a medical supply business allegedly built to collect without supplying.

Medicare Stopped Payments, Supplemental Insurers Paid

The Justice Department reported that approximately $4.45 billion was scheduled for Medicare payment. Proactive analysis detected anomalous billing, and the Health and Human Services Office of Inspector General and CMS prevented all but approximately $41 million from reaching the organization. Meanwhile, Medicare supplemental insurers paid approximately $900 million. Medicare stopped nearly all of its scheduled payments. The supplemental insurers paid. The Department of Health and Human Services and CMS said they intended to seek the return of approximately $4.41 billion held in escrow to the Medicare trust fund.

The mechanics of how Medicare pays help explain the gaps. A supplier’s submitted charge, Medicare’s allowed amount and the program’s payment are different figures. The remittance describes the payment decision and adjustments. The bank transfer shows money moving. A supplemental insurer has its own payment record. Someone working in billing or accounts receivable may see those differences every day, even when a national headline flattens them into one dollar amount.

Data Analytics Finds the Pattern, Business Records Explain It

The takedown paired claims analysis with work across agencies. The Justice Department announced that it was working with the Health and Human Services Office of Inspector General, the FBI and other partners to create a Health Care Fraud Data Fusion Center using cloud computing, artificial intelligence and advanced analytics. Its Health Care Fraud Unit had established an in-house Data Analytics Team in 2018. In Gold Rush, the department credited proactive analysis with detecting the billing pattern that led to payment intervention.

The pressure to move claims quickly has a much longer history. The Congressional Research Service’s 2011 report, Medicare Program Integrity: Activities to Protect Medicare from Payment Errors, Fraud, and Abuse, connected that pressure to a familiar problem:

Requirements to process and pay provider reimbursement claims quickly, have set up a “pay and chase” approach that complicates program integrity efforts.

Medicare Program Integrity: Activities to Protect Medicare from Payment Errors, Fraud, and Abuse, Congressional Research Service, 2011

Gold Rush put the timing problem in concrete terms. Detecting the claims before money left Medicare protected funds that would otherwise have required pursuit.

The 2018 Journal of Big Data study Big Data fraud detection using multiple medicare data sources examined physician and supplier, prescription and equipment-referral data together. The researchers recommended the combined approach because a physician’s fraudulent activity could fall in any of the Medicare data streams they examined.

That study explains the value of looking across payment streams. An insider adds a different kind of connection: whether the order was genuine, whether the product arrived, who supplied the billing instructions and who could move the proceeds. Claims data can reveal a surge. Business records can explain how it happened.

The Same Announcement Reached Very Different Businesses

The cases ranged from durable medical equipment suppliers and laboratories to wound-care providers, pharmacies and addiction-treatment businesses. The allegations included unnecessary treatment, kickbacks and services never provided.

In a separate criminal case described in the national announcement, prosecutors charged owners and executives of marketing organizations with obtaining Medicare beneficiaries’ identifying information through theft and deceptive marketing. According to the court documents summarized by the Justice Department, defendants allegedly used artificial intelligence to create recordings of beneficiaries supposedly consenting to products. The court documents alleged that they sold the information to laboratories and durable medical equipment companies for use in claims.

The alleged scheme generated approximately $703 million in claims to Medicare and Medicare Advantage plans, which paid approximately $418 million on those claims. For a laboratory or supplier employee, the origin of the order matters: who obtained the information, what the patient actually requested and how that request became a bill. An apparently recorded consent can be part of the allegation itself.

Wound Care Chosen for the Bill

Criminal charges against seven defendants in Arizona and Nevada concerned approximately $1.1 billion in allegedly fraudulent claims for amniotic wound allografts to Medicare and other health care benefit programs. The criminal charges alleged that vulnerable elderly patients, including people receiving hospice care, received medically unnecessary grafts, sometimes without coordination with treating physicians or proper infection treatment.

The allegations included applications to superficial wounds and areas far larger than the wounds. That puts the treatment record beside the billed product: the patient’s condition, the area treated and the clinical decision explain what a dollar total cannot. The alleged harm reached patients as well as taxpayers.

Telemedicine, Genetic Testing and Prescription Drugs

The telemedicine and genetic-testing charges involved 49 defendants and more than $1.17 billion in allegedly fraudulent Medicare claims. The Justice Department described deceptive telemarketing that led to equipment and genetic-test billing. The relevant connection runs from the marketing contact through the order to the supplier’s or laboratory’s claim.

The prescription-drug cases charged 74 defendants across 58 cases involving alleged diversion of more than 15 million prescription opioid and other controlled-substance pills. That allegation concerns distribution of drugs. Other pharmacy cases concerned billing for drugs never dispensed. One indictment filed during the takedown period compared billed drugs with wholesaler purchases and alleged concealed pharmacy ownership. Those purchasing and ownership records tell a different story from the prescription alone.

For Medicare Part D fraud, the pharmacy transaction also feeds a broader payment system. A pharmacy claim, a plan sponsor’s prescription drug event record and CMS’s final payment reconciliation perform different jobs. The pharmacy’s gross bill and the federal payment require their own evidence.

Medicaid and Other Payers Had Their Own Cases

The Justice Department also described criminal charges involving an alleged Arizona Medicaid addiction-treatment scheme. The court documents alleged that treatment-center owners paid kickbacks for referrals of people recruited from homeless populations and Native American reservations. Some billed services allegedly never happened. Others were allegedly so poor that they served no treatment purpose.

Across the announcement’s other healthcare schemes, an additional 170 defendants faced allegations involving more than $1.84 billion in false claims to Medicare, Medicaid and private insurers. Those cases included unnecessary treatment, kickbacks and services never provided.

What an Insider Can Explain That a Claim Cannot

Useful Medicare fraud evidence connects the business decision to the claim and payment. A delivery record addresses whether the patient received equipment. A purchasing record can test a pharmacy’s billed volume. An ownership submission identifies the declared controller, while bank records can show who handled the money. The people who work with those records may know why they disagree.

What happened after someone questioned the billing can be just as revealing. In a separate, earlier hospital case, a whistleblower alleged that University of Colorado Health automatically billed certain emergency-department visits at level five based on repeated vital-sign checks, regardless of the care’s complexity. The complaint described the response to the concern:

[The whistleblower] was told that this issue had been discussed with UCHealth’s CFO and they were told to leave it as is.

United States ex rel. Sanders v. University of Colorado Health, whistleblower’s complaint

That allegation adds the management decision behind the billing rule. The government later alleged ignored employee warnings and repeated high-outlier reports in the hospital’s settlement. A dated warning, who received it and what the company kept billing can explain more than another spreadsheet of unusual claims.

Do You Get a Reward for Reporting Fraud?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The criminal charges describe billing practices an insider may also recognize in a civil whistleblower case: fabricated orders and claims for equipment that never arrived. Your knowledge of who directed the billing and who knew it was false gives us something to pursue beyond the national headline.

You Know the Business Behind the Bill

If you know how a supplier, laboratory, pharmacy or treatment business turned false information into paid claims, speak with our Medicare fraud whistleblower experts. We develop the case strategy with you and bring in Medicare fraud whistleblower lawyers who understand the program and the business involved. We stay beside you as your knowledge of the orders, ownership and money becomes the foundation of the case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365